<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04906499</url>
  </required_header>
  <id_info>
    <org_study_id>21-0614</org_study_id>
    <secondary_id>2KR1372103</secondary_id>
    <nct_id>NCT04906499</nct_id>
  </id_info>
  <brief_title>Preventing Posttraumatic Osteoarthritis With Physical Activity Promotion</brief_title>
  <official_title>Preventing Posttraumatic Osteoarthritis With Physical Activity Promotion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>North Carolina Translational and Clinical Sciences Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Osteoarthritis (OA) is a leading cause of disability worldwide that affects millions of&#xD;
      Americans each year. Posttraumatic OA (PTOA) significantly impacts patients after anterior&#xD;
      cruciate ligament (ACL) injury and ACL reconstruction (ACLR) with approximately 50% of&#xD;
      patients developing PTOA within 20 years of injury or surgery. Knee joint mechanical loading&#xD;
      measured via physical activity (i.e. daily steps) is insufficient in individuals after ACLR&#xD;
      compared to uninjured individuals. Establishing the beneficial effects of physical activity&#xD;
      to promote optimal free-living knee joint mechanical loading and improve knee joint health&#xD;
      will aid in the development of cost-effective interventions that prevent PTOA and health&#xD;
      burden of the disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Osteoarthritis (OA) is a leading cause of disability worldwide resulting in severe&#xD;
      limitations in daily activities and chronic pain. It is estimated that 35% of posttraumatic&#xD;
      OA (PTOA) cases occur after knee injuries and surgeries such as anterior cruciate ligament&#xD;
      (ACL) injury and ACL reconstruction (ACLR). Optimal free-living mechanical loading, which&#xD;
      refers to the forces acting on the knee caused by daily activities, plays an essential role&#xD;
      in maintaining knee articular cartilage health. After ACLR, individuals take fewer steps per&#xD;
      day as compared to uninjured controls. This results in insufficient free-living mechanical&#xD;
      loading to joint tissues and is associated with early PTOA development. Adequate physical&#xD;
      activity (PA) is recommended to help reduce risk of PTOA, but it is unclear how changes in PA&#xD;
      acutely impact knee joint cartilage health. The overall objective of this pretest-posttest&#xD;
      experimental pilot study is to determine how optimizing free-living mechanical loading&#xD;
      through PA promotion improves cartilage composition in individuals who demonstrate&#xD;
      insufficient free-living mechanical loading after ACLR. PA promotion will be delivered over 8&#xD;
      weeks using commercially available PA monitors and the patients' smartphone to provide daily&#xD;
      personalized and achievable step goals to increase daily step counts to a level consistent&#xD;
      with healthy PA participation. The hypothesis for aim 1 is that MRI markers of proteoglycan&#xD;
      density associated with PTOA development will improve after 8-weeks of PA promotion exposure.&#xD;
      hypothesis for aim 2 is that greater changes in steps per day will be associated with&#xD;
      improved proteoglycan density. Change in MRI markers of proteoglycan density and steps per&#xD;
      day will be assessed using a pretest-posttest design in 8 adults who are 6 months to 5 years&#xD;
      post-ACLR with insufficient mechanical loading (&lt;8,000 steps per day)24 and suboptimal&#xD;
      quality of life (quality of life survey&lt;72). Outcomes will be collected before (pretest) and&#xD;
      after (posttest) 8-weeks of PA promotion. For the PA promotion, participants will receive a&#xD;
      text message each morning with a personalized, daily step count goal and a link used to&#xD;
      confirm receipt of the goal. The preceding 10 days of step data will be rank ordered and the&#xD;
      60th percentile step count will be set as the goal for the next day. The proposed work is&#xD;
      innovative, in that this study will use a novel combination of outcomes that will lead to&#xD;
      unprecedented insight into the influence of PA promotion in mitigating early PTOA&#xD;
      development.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>T1rho relaxation times in the medial femoral condyle</measure>
    <time_frame>pre-intervention (baseline)</time_frame>
    <description>MRI marker of T1rho relaxation times of medial femoral articular cartilage (i.e proteoglycan density) at pre-intervention (baseline)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>T1rho relaxation times in the medial femoral condyle</measure>
    <time_frame>post-intervention (~8 weeks)</time_frame>
    <description>MRI marker of T1rho relaxation times of medial femoral articular cartilage (i.e proteoglycan density) at post-intervention (~8 weeks)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>T1rho relaxation times in the lateral femoral condyle</measure>
    <time_frame>pre-intervention (baseline)</time_frame>
    <description>MRI marker of T1rho relaxation times of lateral femoral articular cartilage (i.e proteoglycan density) at pre-intervention (baseline)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>T1rho relaxation times in the lateral femoral condyle</measure>
    <time_frame>post-intervention (~8 weeks)</time_frame>
    <description>MRI marker of T1rho relaxation times of lateral femoral articular cartilage (i.e proteoglycan density) at post-intervention (~8 weeks)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>T1rho relaxation times in the medial tibial condyle</measure>
    <time_frame>pre-intervention (baseline)</time_frame>
    <description>MRI marker of T1rho relaxation times of medial tibial articular cartilage (i.e proteoglycan density) at pre-intervention (baseline)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>T1rho relaxation times in the medial tibial condyle</measure>
    <time_frame>post-intervention (~8 weeks)</time_frame>
    <description>MRI marker of T1rho relaxation times of medial tibial articular cartilage (i.e proteoglycan density) at post-intervention (~8 weeks)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>T1rho relaxation times in the lateral tibial condyle</measure>
    <time_frame>pre-intervention (baseline)</time_frame>
    <description>MRI marker of T1rho relaxation times of lateral tibial articular cartilage (i.e proteoglycan density) at pre-intervention (baseline)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>T1rho relaxation times in the lateral tibial condyle</measure>
    <time_frame>post-intervention (~8 weeks)</time_frame>
    <description>MRI marker of T1rho relaxation times of lateral tibial articular cartilage (i.e proteoglycan density) at post-intervention (~8 weeks)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in daily steps</measure>
    <time_frame>pre-intervention (baseline), post-intervention (~8 weeks)</time_frame>
    <description>change in average steps per day over 7 day physical activity monitor wear pre-intervention (baseline) to approximately 8-weeks after physical activity promotion intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in T1rho relaxation times in the medial femoral condyle</measure>
    <time_frame>pre-intervention (baseline), post-intervention (~8 weeks)</time_frame>
    <description>change in MRI marker of T1rho relaxation times of medial femoral articular cartilage (i.e proteoglycan density) from pre-intervention (baseline) to approximately 8-weeks after physical activity promotion intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in T1rho relaxation times in the medial tibial condyle</measure>
    <time_frame>pre-intervention (baseline), post-intervention (~8 weeks)</time_frame>
    <description>change in MRI marker of T1rho relaxation times of medial tibial articular cartilage (i.e proteoglycan density) from pre-intervention (baseline) to approximately 8-weeks after physical activity promotion intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in T1rho relaxation times in the lateral femoral condyle</measure>
    <time_frame>pre-intervention (baseline), post-intervention (~8 weeks)</time_frame>
    <description>change in MRI marker of T1rho relaxation times of lateral femoral articular cartilage (i.e proteoglycan density) from pre-intervention (baseline) to approximately 8-weeks after physical activity promotion intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in T1rho relaxation times in the lateral tibial condyle</measure>
    <time_frame>pre-intervention (baseline), post-intervention (~8 weeks)</time_frame>
    <description>change in MRI marker of T1rho relaxation times of lateral tibial articular cartilage (i.e proteoglycan density) from pre-intervention (baseline) to approximately 8-weeks after physical activity promotion intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knee Injury and Osteoarthritis Outcome Score Quality of Life subscale</measure>
    <time_frame>pre-intervention (baseline)</time_frame>
    <description>Knee injury Osteoarthritis Outcome Score (KOOS) Quality of Life subscale to measure knee-related quality of life at pre-intervention (baseline). A higher score indicates better knee-related quality of life. Min = 0 and Max = 100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee Injury and Osteoarthritis Outcome Score Quality of Life subscale</measure>
    <time_frame>post-intervention (~8 weeks)</time_frame>
    <description>Knee injury Osteoarthritis Outcome Score Quality of Life subscale (KOOS) Quality of Life subscale to measure knee-related quality of life at post-intervention. A higher score indicates better knee-related quality of life. Min = 0 and Max = 100</description>
  </secondary_outcome>
  <other_outcome>
    <measure>physical activity promotion intervention retention</measure>
    <time_frame>post-intervention (~8 weeks)</time_frame>
    <description>percentage of patients retained at post-intervention visit (~8 weeks)</description>
  </other_outcome>
  <other_outcome>
    <measure>physical activity promotion intervention compliance</measure>
    <time_frame>up to post-intervention (~8 weeks)</time_frame>
    <description>percentage of days participant is compliant with fitbit monitor wear (&gt;1,000 steps per day)</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Anterior Cruciate Ligament Injuries</condition>
  <condition>Exercise</condition>
  <condition>Cartilage, Articular</condition>
  <condition>Knee Injuries</condition>
  <condition>Osteoarthritis</condition>
  <condition>Osteoarthritis, Knee</condition>
  <condition>Arthritis</condition>
  <condition>Joint Diseases</condition>
  <arm_group>
    <arm_group_label>Physical Activity Promotion Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive a text message each morning with a personalized, daily step count goal and a link used to confirm receipt of the goal. The preceding 10 days of step data will be rank ordered and the 60th percentile step count will be set as the goal for the next day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Physical Activity Promotion</intervention_name>
    <description>After enrolling, participants will be outfitted with a Fitbit Charge 2 activity monitor. The monitor will be worn during all waking hours, and compliance will be considered as a day with ≥ 1,000 steps. Participants will complete a 14-day &quot;run-in&quot; observation period while wearing the Fitbit but no PA promotion will occur. Individuals who are noncompliant during the &quot;run in&quot; period (&lt;10 days with &lt;1,000 steps) will be removed. Participants will receive a text message each morning with a personalized, daily step count goal and a link used to confirm receipt of the goal. The preceding 10 days of step data will be rank ordered and the 60th percentile step count will be set as the goal for the next day.</description>
    <arm_group_label>Physical Activity Promotion Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
        Participants will be included if they:&#xD;
&#xD;
          -  Provide informed consent and sign a HIPPA form prior to any study procedures are&#xD;
             performed&#xD;
&#xD;
          -  Have completed all other formal physical therapy and therapeutic exercise regimens,&#xD;
             and will not be engaging in any other formal therapy for their ACLR during the study&#xD;
&#xD;
          -  Are between the ages of 18 and 35.&#xD;
&#xD;
          -  Underwent an ACLR no earlier than 6 months and no later than 5 years prior to&#xD;
             enrollment.&#xD;
&#xD;
          -  Demonstrate &lt; 8,000 steps per day during the screening phase of the study as assessed&#xD;
             using the Actigraph GT9X Link monitor.&#xD;
&#xD;
          -  Demonstrate clinically relevant-knee symptoms, defined as a Knee Injury and&#xD;
             Osteoarthritis Outcomes Score (KOOS) quality of life subscale &lt; 72.2&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
        Participants will be excluded if:&#xD;
&#xD;
          -  The participant underwent an ACLR revision surgery due to a previous ACL graft injury.&#xD;
&#xD;
          -  Had ACLR in both limbs&#xD;
&#xD;
          -  Multiple ligament surgery was indicated at the time of ACLR surgery.&#xD;
&#xD;
          -  A lower extremity fracture was suffered during the ACL injury.&#xD;
&#xD;
          -  The participant has been diagnosed with osteoarthritis in either knee&#xD;
&#xD;
          -  They have a cochlear implant, metal in body, claustrophobia, or history of seizures.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian Pietrosimone, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina, Chapel Hill</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Caroline M Lisee, PhD</last_name>
    <phone>19199622025</phone>
    <email>liseecar@email.unc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fetzer Hall, University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline M Lisee</last_name>
      <phone>919-962-2025</phone>
      <email>liseecar@email.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Caroline Lisee, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brian Pietrosimone, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014 Jul;73(7):1323-30. doi: 10.1136/annrheumdis-2013-204763. Epub 2014 Feb 19.</citation>
    <PMID>24553908</PMID>
  </reference>
  <reference>
    <citation>Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008 Jan;58(1):26-35. doi: 10.1002/art.23176.</citation>
    <PMID>18163497</PMID>
  </reference>
  <reference>
    <citation>Furner SE, Hootman JM, Helmick CG, Bolen J, Zack MM. Health-related quality of life of US adults with arthritis: analysis of data from the behavioral risk factor surveillance system, 2003, 2005, and 2007. Arthritis Care Res (Hoboken). 2011 Jun;63(6):788-99. doi: 10.1002/acr.20430.</citation>
    <PMID>21538946</PMID>
  </reference>
  <reference>
    <citation>Alkan BM, Fidan F, Tosun A, Ardıçoğlu O. Quality of life and self-reported disability in patients with knee osteoarthritis. Mod Rheumatol. 2014 Jan;24(1):166-71. doi: 10.3109/14397595.2013.854046.</citation>
    <PMID>24261774</PMID>
  </reference>
  <reference>
    <citation>Brown TD, Johnston RC, Saltzman CL, Marsh JL, Buckwalter JA. Posttraumatic osteoarthritis: a first estimate of incidence, prevalence, and burden of disease. J Orthop Trauma. 2006 Nov-Dec;20(10):739-44.</citation>
    <PMID>17106388</PMID>
  </reference>
  <reference>
    <citation>Luc B, Gribble PA, Pietrosimone BG. Osteoarthritis prevalence following anterior cruciate ligament reconstruction: a systematic review and numbers-needed-to-treat analysis. J Athl Train. 2014 Nov-Dec;49(6):806-19. doi: 10.4085/1062-6050-49.3.35. Review.</citation>
    <PMID>25232663</PMID>
  </reference>
  <reference>
    <citation>Murphy L, Schwartz TA, Helmick CG, Renner JB, Tudor G, Koch G, Dragomir A, Kalsbeek WD, Luta G, Jordan JM. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 2008 Sep 15;59(9):1207-13. doi: 10.1002/art.24021.</citation>
    <PMID>18759314</PMID>
  </reference>
  <reference>
    <citation>Andriacchi TP, Mündermann A. The role of ambulatory mechanics in the initiation and progression of knee osteoarthritis. Curr Opin Rheumatol. 2006 Sep;18(5):514-8. Review.</citation>
    <PMID>16896293</PMID>
  </reference>
  <reference>
    <citation>Bell DR, Pfeiffer KA, Cadmus-Bertram LA, Trigsted SM, Kelly A, Post EG, Hart JM, Cook DB, Dunn WR, Kuenze C. Objectively Measured Physical Activity in Patients After Anterior Cruciate Ligament Reconstruction. Am J Sports Med. 2017 Jul;45(8):1893-1900. doi: 10.1177/0363546517698940. Epub 2017 Apr 18.</citation>
    <PMID>28419817</PMID>
  </reference>
  <reference>
    <citation>Nelson AE, Allen KD, Golightly YM, Goode AP, Jordan JM. A systematic review of recommendations and guidelines for the management of osteoarthritis: The chronic osteoarthritis management initiative of the U.S. bone and joint initiative. Semin Arthritis Rheum. 2014 Jun;43(6):701-12. doi: 10.1016/j.semarthrit.2013.11.012. Epub 2013 Dec 4. Review.</citation>
    <PMID>24387819</PMID>
  </reference>
  <reference>
    <citation>Palmieri-Smith RM, Cameron KL, DiStefano LJ, Driban JB, Pietrosimone B, Thomas AC, Tourville TW, Consortium ATO. The Role of Athletic Trainers in Preventing and Managing Posttraumatic Osteoarthritis in Physically Active Populations: a Consensus Statement of the Athletic Trainers' Osteoarthritis Consortium. J Athl Train. 2017 Jun 2;52(6):610-623. doi: 10.4085/1062-6050-52.2.04.</citation>
    <PMID>28653866</PMID>
  </reference>
  <reference>
    <citation>Tudor-Locke C, Craig CL, Brown WJ, Clemes SA, De Cocker K, Giles-Corti B, Hatano Y, Inoue S, Matsudo SM, Mutrie N, Oppert JM, Rowe DA, Schmidt MD, Schofield GM, Spence JC, Teixeira PJ, Tully MA, Blair SN. How many steps/day are enough? For adults. Int J Behav Nutr Phys Act. 2011 Jul 28;8:79. doi: 10.1186/1479-5868-8-79. Review.</citation>
    <PMID>21798015</PMID>
  </reference>
  <reference>
    <citation>Ingelsrud LH, Granan LP, Terwee CB, Engebretsen L, Roos EM. Proportion of Patients Reporting Acceptable Symptoms or Treatment Failure and Their Associated KOOS Values at 6 to 24 Months After Anterior Cruciate Ligament Reconstruction: A Study From the Norwegian Knee Ligament Registry. Am J Sports Med. 2015 Aug;43(8):1902-7. doi: 10.1177/0363546515584041. Epub 2015 May 14.</citation>
    <PMID>25977523</PMID>
  </reference>
  <reference>
    <citation>Roos EM, Toksvig-Larsen S. Knee injury and Osteoarthritis Outcome Score (KOOS) - validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes. 2003 May 25;1:17.</citation>
    <PMID>12801417</PMID>
  </reference>
  <reference>
    <citation>Pfeiffer S, Harkey MS, Stanley LE, Blackburn JT, Padua DA, Spang JT, Marshall SW, Jordan JM, Schmitz R, Nissman D, Pietrosimone B. Associations Between Slower Walking Speed and T1ρ Magnetic Resonance Imaging of Femoral Cartilage Following Anterior Cruciate Ligament Reconstruction. Arthritis Care Res (Hoboken). 2018 Aug;70(8):1132-1140. doi: 10.1002/acr.23477. Epub 2018 Jul 4.</citation>
    <PMID>29193888</PMID>
  </reference>
  <reference>
    <citation>Pietrosimone B, Nissman D, Padua DA, Blackburn JT, Harkey MS, Creighton RA, Kamath GM, Healy K, Schmitz R, Driban JB, Marshall SW, Jordan JM, Spang JT. Associations between cartilage proteoglycan density and patient outcomes 12months following anterior cruciate ligament reconstruction. Knee. 2018 Jan;25(1):118-129. doi: 10.1016/j.knee.2017.10.005. Epub 2018 Jan 9.</citation>
    <PMID>29329888</PMID>
  </reference>
  <reference>
    <citation>Freedson PS, Melanson E, Sirard J. Calibration of the Computer Science and Applications, Inc. accelerometer. Med Sci Sports Exerc. 1998 May;30(5):777-81.</citation>
    <PMID>9588623</PMID>
  </reference>
  <reference>
    <citation>McClain JJ, Sisson SB, Tudor-Locke C. Actigraph accelerometer interinstrument reliability during free-living in adults. Med Sci Sports Exerc. 2007 Sep;39(9):1509-14.</citation>
    <PMID>17805082</PMID>
  </reference>
  <reference>
    <citation>Roos EM, Roos HP, Ekdahl C, Lohmander LS. Knee injury and Osteoarthritis Outcome Score (KOOS)--validation of a Swedish version. Scand J Med Sci Sports. 1998 Dec;8(6):439-48.</citation>
    <PMID>9863983</PMID>
  </reference>
  <reference>
    <citation>Salavati M, Akhbari B, Mohammadi F, Mazaheri M, Khorrami M. Knee injury and Osteoarthritis Outcome Score (KOOS); reliability and validity in competitive athletes after anterior cruciate ligament reconstruction. Osteoarthritis Cartilage. 2011 Apr;19(4):406-10. doi: 10.1016/j.joca.2011.01.010. Epub 2011 Jan 19.</citation>
    <PMID>21255667</PMID>
  </reference>
  <reference>
    <citation>Xu X, Tupy S, Robertson S, Miller AL, Correll D, Tivis R, Nigg CR. Successful adherence and retention to daily monitoring of physical activity: Lessons learned. PLoS One. 2018 Sep 20;13(9):e0199838. doi: 10.1371/journal.pone.0199838. eCollection 2018.</citation>
    <PMID>30235221</PMID>
  </reference>
  <reference>
    <citation>Adams MA, Sallis JF, Norman GJ, Hovell MF, Hekler EB, Perata E. An adaptive physical activity intervention for overweight adults: a randomized controlled trial. PLoS One. 2013 Dec 9;8(12):e82901. doi: 10.1371/journal.pone.0082901. eCollection 2013.</citation>
    <PMID>24349392</PMID>
  </reference>
  <reference>
    <citation>Hurley JC, Hollingshead KE, Todd M, Jarrett CL, Tucker WJ, Angadi SS, Adams MA. The Walking Interventions Through Texting (WalkIT) Trial: Rationale, Design, and Protocol for a Factorial Randomized Controlled Trial of Adaptive Interventions for Overweight and Obese, Inactive Adults. JMIR Res Protoc. 2015 Sep 11;4(3):e108. doi: 10.2196/resprot.4856.</citation>
    <PMID>26362511</PMID>
  </reference>
  <reference>
    <citation>Kuenze C, Lisee C, Pfeiffer KA, Cadmus-Bertram L, Post EG, Biese K, Bell DR. Sex differences in physical activity engagement after ACL reconstruction. Phys Ther Sport. 2019 Jan;35:12-17. doi: 10.1016/j.ptsp.2018.10.016. Epub 2018 Oct 26.</citation>
    <PMID>30396146</PMID>
  </reference>
  <reference>
    <citation>Kuenze C, Cadmus-Bertram L, Pfieffer K, Trigsted S, Cook D, Lisee C, Bell D. Relationship Between Physical Activity and Clinical Outcomes After ACL Reconstruction. J Sport Rehabil. 2019 Feb 1;28(2):180-187. doi: 10.1123/jsr.2017-0186. Epub 2018 Oct 15.</citation>
    <PMID>29140161</PMID>
  </reference>
  <reference>
    <citation>Lisee CM, Montoye AHK, Lewallen NF, Hernandez M, Bell DR, Kuenze CM. Assessment of Free-Living Cadence Using ActiGraph Accelerometers Between Individuals With and Without Anterior Cruciate Ligament Reconstruction. J Athl Train. 2020 Sep 1;55(9):994-1000. doi: 10.4085/1062-6050-425-19.</citation>
    <PMID>32818959</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 25, 2021</study_first_submitted>
  <study_first_submitted_qc>May 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2021</study_first_posted>
  <last_update_submitted>August 5, 2021</last_update_submitted>
  <last_update_submitted_qc>August 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Knee Injuries</mesh_term>
    <mesh_term>Anterior Cruciate Ligament Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.</ipd_description>
    <ipd_time_frame>9 to 36 months</ipd_time_frame>
    <ipd_access_criteria>The investigator who proposes to use the data has approval from an IRB, IEC, or REB, as applicable, and an executed data use/sharing agreement with UNC.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

